InvestorsHub Logo
Followers 62
Posts 1751
Boards Moderated 0
Alias Born 04/22/2022

Re: dr_lowenstein post# 546772

Friday, 12/09/2022 9:34:49 PM

Friday, December 09, 2022 9:34:49 PM

Post# of 721302
Thanks for asking.

Murcidencel has been studied in three trials and only one had an ECA. But if you want to know about ECA approvals:

45 have been approved on an ECA —that is significant going back 20 yrs in history—only about 40 drugs are approved each year roughly if I recall correctly.

In terms of cancer drugs specifically that were approved on ECAs: Erdafitinib, Selumetinib, Blinatumomab, Keytruda+lenvatinib combo, and several combos for renal cancer … and others that I am sure I have forgotten.

I recommend researching ECA approvals further for yourself. Include RAs abroad and the evolving stance of the FDA toward RWE in your search.



https://www.fda.gov/patients/fast-track-breakthrough-therapy-accelerated-approval-priority-review/fast-track

https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847

Bullish
Bullish

Believe carefully. This is the greatest and most powerful lesson that I have learned since arriving on Earth. Examine what you believe about yourself most importantly, and then believe carefully as you interact with the world.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News